Shortening treatment duration is crucial to improve patient adherence, reduce the risk of drug resistance development, and ultimately, accelerate TB control efforts. UCT Research UCT IDM H3D #tuberculosis doi.org/10.1016/j.drud…

Please Share it: H3D is looking for a Senior Scientist to join as a Chief Investigator and lead the Infectious Diseases Biology jobs.uct.ac.za/job/Cape-Town-…

Tuberculosis (TB) presents a significant global health concern, with an estimated 10 million people developing TB disease and 1.3 million people dying from the disease each year. #EndTB #Tuberculosis #Tuberculosis Awareness #WorldTBDay2024

#DiscoveryBestBank , changed the banking experience - no more wasting time in the queue of ***Bank for even a small query. The rewards are amazing when these are combined with my #DISCOVERYMILES #DiscoveryHealth #DiscoveryVitality #DiscoveryInsure #Insure Atica Moosa

In a thought-provoking review by Mousumi Shyam, Sumit Kumar, and Vinayak Singh, read about unlocking opportunities for Mycobacterium leprae and Mycobacterium ulcerans. #ACSInfectiousDiseases Vinayak Singh UCT IDM H3D

go.acs.org/8a5

H3D is hiring! Are you interested in a microbiology Post-Doctoral Fellowship in Drug Metabolism? See below. #vacancies #drugdiscovery

Truly inspiring

Looking for postdoc in TB drug discovery? Apply quickly

Kindly share within your Network.

Postdoctoral vacancy: We have a postdoctoral opportunity to work on a super exciting and well-defined project in our Team/group at the University of Cape Town. #work #share #network #university #drug discovery #tuberculosis H3D UCT IDM

Interested in learning what we do? Do visit us H3D Kelly Chibale #UCT_Open_day

Looking forward to working with BMC Series #bmcmicro H3D #tuberculosis #drugdiscovery #drugresistance

POSTDOCTORAL VACANCY: We are looking for a postdoc to work on an exciting project (Mycobacterium tuberculosis-mediated metabolism of drugs). Please Share it.
H3D Kelly Chibale #tuberculosis #DrugDiscovery #metabolism #mycobacteria
linkedin.com/posts/vinayak-…

Interested in Imidazo[1,2-a]pyridine class? Enjoy reading this critical review UCT IDM H3D #tuberculosis #drugdiscovery #Science

Read my latest #research on #mycobacterium tuberculosis-mediated drug metabolism, published with Springer Nature in Nature Reviews Chemistry with Kelly Chibale and Godwin #Tuberculosis #drugdiscovery H3D UCT IDM
protect-za.mimecast.com/s/DgSFCk5jm7SO…

Remember to join us at 12pm today!

H3D's Dr Vinayak Singh & Dr Godwin Dziwornu will be presenting on 'The implication of Mycobacterium tuberculosis-mediated metabolism of targeted xenobiotics'.

You can access the webinar via this link: meet.zoho.com/ibNtX5KHi2

Looking forward to share our thoughts on Mtb-mediated metabolism of xenobiotics at 12 pm on 22 March. Do join us, access is free 😁

Inoculum-dependent bactericidal activity of a Mycobacterium tuberculosis MmpL3 inhibitor biorxiv.org/content/10.110…

The burden of drug-resistant TB increased by 3% between 2020 and 2021. Please do your part and contribute to this special issue edited by Dr. Uma Gautam and me. H3D #DrugDiscovery #tuberculosis #drugresistance UCT IDM

A textbook-like collaborative MoA work of identifying/validating the HadAB/BC as a target of 1,3-Diarylpyrazolyl-acylsulfonamides Kelly Chibale H3D UCT IDM #tuberculosis #drugdiscovery #collaboration pubs.acs.org/doi/10.1021/ac…

We are excited to engage Vinayak Singh as we discuss pressing issues from #DrugDiscovery to #AntimicrobialResistance . Register here: h3dsymposium.co.za/registration to attend the #H3DSymposium at Meet in Cape Town #WhereMeetingsMatter #WhereGreatMindsMeet